CLINICAL_TRIALS
trial_result
· 2019-09-11
Clinical Trial Update: A Study of LY2940680 in Japanese Participants With Advanced Cancers [Phase 1]
Summary
Phase 1 clinical trial update for LY2940680 in Japanese participants with advanced cancers has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Neoplasm Metastasis | Phase 1 | Status: COMPLETED | Results posted: 2019-09-11